The DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.
Beyond binding: antibody effector functions in infectious diseases
Open accessAbstract
Antibodies play an essential role in host defence against pathogens by binding to microorganisms and infected cells and exerting various effector functions. In this Review, Lu and colleagues summarize antibody isotypes and subclasses, modifications, receptor binding and signalling and effector functions in the context of infectious diseases. Antibodies play an essential role in host defence against pathogens by recognizing microorganisms or infected cells. Although preventing pathogen entry is one potential mechanism of protection, antibodies can control and eradicate infections through a variety of other mechanisms. In addition to binding and directly neutralizing pathogens, antibodies drive the clearance of bacteria, viruses, fungi and parasites via their interaction with the innate and adaptive immune systems, leveraging a remarkable diversity of antimicrobial processes locked within our immune system. Specifically, antibodies collaboratively form immune complexes that drive sequestration and uptake of pathogens, clear toxins, eliminate infected cells, increase antigen presentation and regulate inflammation. The diverse effector functions that are deployed by antibodies are dynamically regulated via differential modification of the antibody constant domain, which provides specific instructions to the immune system. Here, we review mechanisms by which antibody effector functions contribute to the balance between microbial clearance and pathology and discuss tractable lessons that may guide rational vaccine and therapeutic design to target gaps in our infectious disease armamentarium.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908492 · Cited by 3,034
Fcγ receptors as regulators of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2206 · Cited by 2,947
FcRn: the neonatal Fc receptor comes of age
Roopenian, D. C., & Akilesh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2155 · Cited by 2,346
Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Haynes, B. F., Gilbert, P. B., McElrath, M. J., Zolla-Pazner, S., Tomaras, G. D., Alam, S. M., Evans, D. T., Montefiori, D. C., Karnasuta, C., Sutthent, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113425 · Cited by 1,808
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Walker, L. M., Phogat, S. K., Chan-Hui, P.-Y., Wagner, D., Phung, P., Goss, J. L., Wrin, T., Simek, M. D., Fling, S., Mitcham, J. L., et al. (2009) · Science · doi:10.1126/science.1178746 · Cited by 1,723
Complement System Part I – Molecular Mechanisms of Activation and Regulation
Merle, N. S., Church, S. E., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00262 · Cited by 1,620
Bruhns, P., Iannascoli, B., England, P., Mancardi, D. A., Fernandez, N., Jorieux, S., & Daëron, M. (2009) · Blood · doi:10.1182/blood-2008-09-179754 · Cited by 1,479
The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins
Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,307
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Goldschneider, I., Gotschlich, E. C., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1307 · Cited by 1,294
The therapeutic monoclonal antibody market
Ecker, D. M., Jones, S. D., & Levine, H. L. (2015) · mAbs · doi:10.4161/19420862.2015.989042 · Cited by 1,286
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
Richman, D. D., Wrin, T., Little, S. J., & Petropoulos, C. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630530100 · Cited by 1,200
Immunological mechanisms of vaccination
Pulendran, B., & Ahmed, R. (2011) · Nature Immunology · doi:10.1038/ni.2039 · Cited by 1,089
Complement System Part II: Role in Immunity
Merle, N. S., Noe, R., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00257 · Cited by 1,051
Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding
Nimmerjahn, F., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1118948 · Cited by 1,037
The immune geography of IgA induction and function
Macpherson, A. J., McCoy, K. D., Johansen, F.-E., & Brandtzaeg, P. (2008) · Mucosal Immunology · doi:10.1038/mi.2007.6 · Cited by 1,028
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Goldschneider, I., Gotschlich, E. C., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1327 · Cited by 995
Germinal Center B Cell Dynamics
Mesin, L., Ersching, J., & Victora, G. D. (2016) · Immunity · doi:10.1016/j.immuni.2016.09.001 · Cited by 994
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
Qiu, X., Wong, G., Audet, J., Bello, A., Fernando, L., Alimonti, J. B., Fausther-Bovendo, H., Wei, H., Aviles, J., Hiatt, E., et al. (2014) · Nature · doi:10.1038/nature13777 · Cited by 987
Programming the magnitude and persistence of antibody responses with innate immunity
Kasturi, S. P., Skountzou, I., Albrecht, R. A., Koutsonanos, D., Hua, T., Nakaya, H. I., Ravindran, R., Stewart, S., Alam, M., Kwissa, M., et al. (2011) · Nature · doi:10.1038/nature09737 · Cited by 975
Dejnirattisai, W., Supasa, P., Wongwiwat, W., Rouvinski, A., Barba-Spaeth, G., Duangchinda, T., Sakuntabhai, A., Cao-Lormeau, V.-M., Malasit, P., Rey, F. A., et al. (2016) · Nature Immunology · doi:10.1038/ni.3515 · Cited by 914
Fc receptor but not complement binding is important in antibody protection against HIV
Hessell, A. J., Hangartner, L., Hunter, M., Havenith, C. E. G., Beurskens, F. J., Bakker, J. M., Lanigan, C. M. S., Landucci, G., Forthal, D. N., Parren, P. W. H. I., et al. (2007) · Nature · doi:10.1038/nature06106 · Cited by 901
The movers and shapers in immune privilege of the CNS
Engelhardt, B., Vajkoczy, P., & Weller, R. O. (2017) · Nature Immunology · doi:10.1038/ni.3666 · Cited by 893
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
Wilcox, M. H., Gerding, D. N., Poxton, I. R., Kelly, C., Nathan, R., Birch, T., Cornely, O. A., Rahav, G., Bouza, E., Lee, C., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1602615 · Cited by 858
Properties of mouse and human IgG receptors and their contribution to disease models
Bruhns, P. (2012) · Blood · doi:10.1182/blood-2012-01-380121 · Cited by 847
Systems biology of vaccination for seasonal influenza in humans
Nakaya, H. I., Wrammert, J., Lee, E. K., Racioppi, L., Marie-Kunze, S., Haining, W. N., Means, A. R., Kasturi, S. P., Khan, N., Li, G.-M., et al. (2011) · Nature Immunology · doi:10.1038/ni.2067 · Cited by 809
Complement Is Activated by IgG Hexamers Assembled at the Cell Surface
Diebolder, C. A., Beurskens, F. J., de Jong, R. N., Koning, R. I., Strumane, K., Lindorfer, M. A., Voorhorst, M., Ugurlar, D., Rosati, S., Heck, A. J. R., et al. (2014) · Science · doi:10.1126/science.1248943 · Cited by 796
Ferrara, C., Grau, S., Jäger, C., Sondermann, P., Brünker, P., Waldhauer, I., Hennig, M., Ruf, A., Rufer, A. C., Stihle, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108455108 · Cited by 770
Umaña, P., Jean–Mairet, J., Moudry, R., Amstutz, H., & Bailey, J. E. (1999) · Nature Biotechnology · doi:10.1038/6179 · Cited by 764
DiLillo, D. J., Tan, G. S., Palese, P., & Ravetch, J. V. (2014) · Nature Medicine · doi:10.1038/nm.3443 · Cited by 749
Building better monoclonal antibody-based therapeutics
Weiner, G. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3930 · Cited by 712
Wu, J., Edberg, J. C., Redecha, P. B., Bansal, V, Guyre, P. M., Coleman, K., Salmon, J. E., & Kimberly, R. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119616 · Cited by 711
THE NATURAL-SELECTION THEORY OF ANTIBODY FORMATION
Jerne, N. K. (1955) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.41.11.849 · Cited by 696
Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells
Phan, T. G., Grigorova, I., Okada, T., & Cyster, J. G. (2007) · Nature Immunology · doi:10.1038/ni1494 · Cited by 656
Barouch, D. H., Whitney, J. B., Moldt, B., Klein, F., Oliveira, T. Y., Liu, J., Stephenson, K. E., Chang, H.-W., Shekhar, K., Gupta, S., et al. (2013) · Nature · doi:10.1038/nature12744 · Cited by 644
Ueber das Zustandekommen der Diphtherie-Immunität und der Tetanus-Immunität bei Thieren
(1890) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0029-1207589 · Cited by 643
The function of Fcγ receptors in dendritic cells and macrophages
Guilliams, M., Bruhns, P., Saeys, Y., Hammad, H., & Lambrecht, B. N. (2014) · Nature Reviews Immunology · doi:10.1038/nri3582 · Cited by 639
The importance of natural IgM: scavenger, protector and regulator
Ehrenstein, M. R., & Notley, C. A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2849 · Cited by 635
Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway
Anthony, R. M., Kobayashi, T., Wermeling, F., & Ravetch, J. V. (2011) · Nature · doi:10.1038/nature10134 · Cited by 633
Beltramello, M., Williams, K. L., Simmons, C. P., Macagno, A., Simonelli, L., Quyen, N. T. H., Sukupolvi-Petty, S., Navarro-Sanchez, E., Young, P. R., de Silva, A. M., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.08.007 · Cited by 592
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge
Law, M., Maruyama, T., Lewis, J., Giang, E., Tarr, A. W., Stamataki, Z., Gastaminza, P., Chisari, F. V., Jones, I. M., Fox, R. I., et al. (2008) · Nature Medicine · doi:10.1038/nm1698 · Cited by 591
A Functional Role for Antibodies in Tuberculosis
Lu, L. L., Chung, A. W., Rosebrock, T. R., Ghebremichael, M., Yu, W. H., Grace, P. S., Schoen, M. K., Tafesse, F., Martin, C., Leung, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.072 · Cited by 571
Self-citationIdentification of a receptor required for the anti-inflammatory activity of IVIG
Anthony, R. M., Wermeling, F., Karlsson, M. C. I., & Ravetch, J. V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810163105 · Cited by 547
Passive antibody therapy for infectious diseases
Casadevall, A., Dadachova, E., & Pirofski, L.-A. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro974 · Cited by 531
High-affinity IgE receptor on eosinophils is involved in defence against parasites
Soussi Gounni, A., Lamkhioued, B., Ochiai, K., Tanaka, Y., Delaporte, E., Capron, A., Kinet, J.-P., & Capron, M. (1994) · Nature · doi:10.1038/367183a0 · Cited by 517
The role of IL-10 in promoting disease progression in Leishmaniasis
Kane, M. M., & Mosser, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.1141 · Cited by 514
Type I and type II Fc receptors regulate innate and adaptive immunity
Pincetic, A., Bournazos, S., DiLillo, D. J., Maamary, J., Wang, T. T., Dahan, R., Fiebiger, B.-M., & Ravetch, J. V. (2014) · Nature Immunology · doi:10.1038/ni.2939 · Cited by 514
Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
Bournazos, S., Klein, F., Pietzsch, J., Seaman, M. S., Nussenzweig, M. C., & Ravetch, J. V. (2014) · Cell · doi:10.1016/j.cell.2014.08.023 · Cited by 493
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
Caskey, M., Schoofs, T., Gruell, H., Settler, A., Karagounis, T., Kreider, E. F., Murrell, B., Pfeifer, N., Nogueira, L., Oliveira, T. Y., et al. (2017) · Nature Medicine · doi:10.1038/nm.4268 · Cited by 487
Zhang, W., Gordon, M., Schultheis, A. M., Yang, D. Y., Nagashima, F., Azuma, M., Chang, H.-M., Borucka, E., Lurje, G., Sherrod, A. E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.8021 · Cited by 482
Karsten, C. M., Pandey, M. K., Figge, J., Kilchenstein, R., Taylor, P. R., Rosas, M., McDonald, J. U., Orr, S. J., Berger, M., Petzold, D., et al. (2012) · Nature Medicine · doi:10.1038/nm.2862 · Cited by 479
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
Scheid, J. F., Horwitz, J. A., Bar-On, Y., Kreider, E. F., Lu, C.-L., Lorenzi, J. C. C., Feldmann, A., Braunschweig, M., Nogueira, L., Oliveira, T., et al. (2016) · Nature · doi:10.1038/nature18929 · Cited by 472
Lynch, R. M., Boritz, E., Coates, E. E., DeZure, A., Madden, P., Costner, P., Enama, M. E., Plummer, S., Holman, L., Hendel, C. S., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad5752 · Cited by 465
Moldt, B., Rakasz, E. G., Schultz, N., Chan-Hui, P.-Y., Swiderek, K., Weisgrau, K. L., Piaskowski, S. M., Bergman, Z., Watkins, D. I., Poignard, P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214785109 · Cited by 463
Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia
Shingai, M., Nishimura, Y., Klein, F., Mouquet, H., Donau, O. K., Plishka, R., Buckler-White, A., Seaman, M., Piatak, M., Lifson, J. D., et al. (2013) · Nature · doi:10.1038/nature12746 · Cited by 455
Chen, K., Xu, W., Wilson, M., He, B., Miller, N. W., Bengtén, E., Edholm, E.-S., Santini, P. A., Rath, P., Chiu, A., et al. (2009) · Nature Immunology · doi:10.1038/ni.1748 · Cited by 442
Phalipon, A., Cardona, A., Kraehenbuhl, J.-P., Edelman, L., Sansonetti, P. J., & Corthésy, B. (2002) · Immunity · doi:10.1016/s1074-7613(02)00341-2 · Cited by 426
Mannose-binding lectin and its genetic variants
Garred, P., Larsen, F., Seyfarth, J., Fujita, R., & Madsen, H. O. (2006) · Genes & Immunity · doi:10.1038/sj.gene.6364283 · Cited by 420
Halstead, S. B., Mahalingam, S., Marovich, M. A., Ubol, S., & Mosser, D. M. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70166-3 · Cited by 409
Chung, A. W., Ghebremichael, M., Robinson, H., Brown, E., Choi, I., Lane, S., Dugast, A.-S., Schoen, M. K., Rolland, M., Suscovich, T. J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007736 · Cited by 406
Self-citationInfections of People with Complement Deficiencies and Patients Who Have Undergone Splenectomy
Ram, S., Lewis, L. A., & Rice, P. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00048-09 · Cited by 405
Fc glycans of therapeutic antibodies as critical quality attributes
Reusch, D., & Tejada, M. L. (2015) · Glycobiology · doi:10.1093/glycob/cwv065 · Cited by 404
Cell Surface Recycling of Internalized Antigen Permits Dendritic Cell Priming of B Cells
Bergtold, A., Desai, D. D., Gavhane, A., & Clynes, R. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.013 · Cited by 401
A Role for Immune Complexes in Enhanced Respiratory Syncytial Virus Disease
Polack, F. P., Teng, M. N., L.Collins, P., Prince, G. A., Exner, M., Regele, H., Lirman, D. D., Rabold, R., Hoffman, S. J., Karp, C. L., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020781 · Cited by 400
Hepatitis C Virus E2 Envelope Glycoprotein Core Structure
Kong, L., Giang, E., Nieusma, T., Kadam, R. U., Cogburn, K. E., Hua, Y., Dai, X., Stanfield, R. L., Burton, D. R., Ward, A. B., et al. (2013) · Science · doi:10.1126/science.1243876 · Cited by 398
Human antibody–Fc receptor interactions illuminated by crystal structures
Woof, J. M., & Burton, D. R. (2004) · Nature Reviews Immunology · doi:10.1038/nri1266 · Cited by 387
Structural Basis of Zika Virus-Specific Antibody Protection
Zhao, H., Fernandez, E., Dowd, K. A., Speer, S. D., Platt, D. J., Gorman, M. J., Govero, J., Nelson, C. A., Pierson, T. C., Diamond, M. S., et al. (2016) · Cell · doi:10.1016/j.cell.2016.07.020 · Cited by 375
Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21
McEwan, W. A., Tam, J. C. H., Watkinson, R. E., Bidgood, S. R., Mallery, D. L., & James, L. C. (2013) · Nature Immunology · doi:10.1038/ni.2548 · Cited by 372
Johansen, F.-E., & Kaetzel, C. S. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.37 · Cited by 368
Goncalvez, A. P., Engle, R. E., St. Claire, M., Purcell, R. H., & Lai, C.-J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703498104 · Cited by 364
McKean, D. (2004) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)61579-7 · Cited by 364
Structural basis of West Nile virus neutralization by a therapeutic antibody
Nybakken, G. E., Oliphant, T., Johnson, S., Burke, S., Diamond, M. S., & Fremont, D. H. (2005) · Nature · doi:10.1038/nature03956 · Cited by 352
Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology
Chung, A. W., Kumar, M. P., Arnold, K. B., Yu, W. H., Schoen, M. K., Dunphy, L. J., Suscovich, T. J., Frahm, N., Linde, C., Mahan, A. E., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.027 · Cited by 352
Self-citationEnhanced clearance of HIV-1–infected cells by broadly neutralizing antibodies against HIV-1 in vivo
Lu, C.-L., Murakowski, D. K., Bournazos, S., Schoofs, T., Sarkar, D., Halper-Stromberg, A., Horwitz, J. A., Nogueira, L., Golijanin, J., Gazumyan, A., et al. (2016) · Science · doi:10.1126/science.aaf1279 · Cited by 347
Parren, P. W., Warmerdam, P. A., Boeije, L. C., Arts, J., Westerdaal, N. A., Vlug, A., Capel, P. J., Aarden, L. A., & van de Winkel, J. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116022 · Cited by 346
Barouch, D. H., Stephenson, K. E., Borducchi, E. N., Smith, K., Stanley, K., McNally, A. G., Liu, J., Abbink, P., Maxfield, L. F., Seaman, M. S., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.061 · Cited by 342
Self-citationThe generation of antibody diversity through somatic hypermutation and class switch recombination
Li, Z., Woo, C. J., Iglesias-Ussel, M. D., Ronai, D., & Scharff, M. D. (2004) · Genes & Development · doi:10.1101/gad.1161904 · Cited by 342
Clinical Care of Two Patients with Ebola Virus Disease in the United States
Lyon, G. M., Mehta, A. K., Varkey, J. B., Brantly, K., Plyler, L., McElroy, A. K., Kraft, C. S., Towner, J. S., Spiropoulou, C., Ströher, U., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409838 · Cited by 337
Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody
Nowakowski, A., Wang, C., Powers, D. B., Amersdorfer, P., Smith, T. J., Montgomery, V. A., Sheridan, R., Blake, R., Smith, L. A., & Marks, J. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172229899 · Cited by 331
Reversal of Proinflammatory Responses by Ligating the Macrophage Fcγ Receptor Type I
Sutterwala, F. S., Noel, G. J., Salgame, P., & Mosser, D. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.217 · Cited by 327
Fc Receptors Initiate the Arthus Reaction: Redefining the Inflammatory Cascade
Sylvestre, D. L., & Ravetch, J. V. (1994) · Science · doi:10.1126/science.8066448 · Cited by 321
The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection
Pierson, T. C., Xu, Q., Nelson, S., Oliphant, T., Nybakken, G. E., Fremont, D. H., & Diamond, M. S. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.03.002 · Cited by 308
Boyle, M. J., Reiling, L., Feng, G., Langer, C., Osier, F. H., Aspeling-Jones, H., Cheng, Y. S., Stubbs, J., Tetteh, K. K. A., Conway, D. J., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.012 · Cited by 306
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges
Gautam, R., Nishimura, Y., Pegu, A., Nason, M. C., Klein, F., Gazumyan, A., Golijanin, J., Buckler-White, A., Sadjadpour, R., Wang, K., et al. (2016) · Nature · doi:10.1038/nature17677 · Cited by 306
A new function for platelets: IgE-dependent killing of schistosomes
Joseph, M., Auriault, C., Capron, A., Vorng, H., & Viens, P. (1983) · Nature · doi:10.1038/303810a0 · Cited by 296
Raxibacumab for the Treatment of Inhalational Anthrax
Migone, T.-S., Subramanian, G. M., Zhong, J., Healey, L. M., Corey, A., Devalaraja, M., Lo, L., Ullrich, S., Zimmerman, J., Chen, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810603 · Cited by 294
Systems analysis of protective immune responses to RTS,S malaria vaccination in humans
Kazmin, D., Nakaya, H. I., Lee, E. K., Johnson, M. J., van der Most, R., van den Berg, R. A., Ballou, W. R., Jongert, E., Wille-Reece, U., Ockenhouse, C., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621489114 · Cited by 293
Macrophages are critical effectors of antibody therapies for cancer
Weiskopf, K., & Weissman, I. L. (2015) · mAbs · doi:10.1080/19420862.2015.1011450 · Cited by 292
Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity
Maynard, J. A., Maassen, C. B. M., Leppla, S. H., Brasky, K., Patterson, J. L., Iverson, B. L., & Georgiou, G. (2002) · Nature Biotechnology · doi:10.1038/nbt0602-597 · Cited by 287
Stapleton, N. M., Andersen, J. T., Stemerding, A. M., Bjarnarson, S. P., Verheul, R. C., Gerritsen, J., Zhao, Y., Kleijer, M., Sandlie, I., de Haas, M., et al. (2011) · Nature Communications · doi:10.1038/ncomms1608 · Cited by 286
Transmembrane signaling: the joy of aggregation
Metzger, H. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.5.1477 · Cited by 273
Impact of Immune Complex Size and Glycosylation on IgG Binding to Human FcγRs
Lux, A., Yu, X., Scanlan, C. N., & Nimmerjahn, F. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1200501 · Cited by 272
Elimination of HIV-1-infected cells by broadly neutralizing antibodies
Bruel, T., Guivel-Benhassine, F., Amraoui, S., Malbec, M., Richard, L., Bourdic, K., Donahue, D. A., Lorin, V., Casartelli, N., Noël, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms10844 · Cited by 271
Differential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect
DiLillo, D. J., & Ravetch, J. V. (2015) · Cell · doi:10.1016/j.cell.2015.04.016 · Cited by 266
Dynamics of immunoglobulins at the feto-maternal interface
Saji, F. (1999) · Reviews of Reproduction · doi:10.1530/revreprod/4.2.81 · Cited by 265
Signalling C ‐Type lectin receptors, microbial recognition and immunity
Hoving, J. C., Wilson, G. J., & Brown, G. D. (2014) · Cellular Microbiology · doi:10.1111/cmi.12249 · Cited by 262
Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control
Ackerman, M. E., Mikhailova, A., Brown, E. P., Dowell, K. G., Walker, B. D., Bailey-Kellogg, C., Suscovich, T. J., & Alter, G. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005315 · Cited by 258
Self-citationFlexibility of human IgG subclasses
Roux, K. H., Strelets, L., & Michaelsen, T. E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3372 · Cited by 254
Isotype and glycoform selection for antibody therapeutics
Jefferis, R. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.03.021 · Cited by 252
Complex Correlates of Protection After Vaccination
Plotkin, S. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit048 · Cited by 240
Boehm, M. K., Woof, J. M., Kerr, M. A., & Perkins, S. J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2556 · Cited by 233
Zeitlin, L., Pettitt, J., Scully, C., Bohorova, N., Kim, D., Pauly, M., Hiatt, A., Ngo, L., Steinkellner, H., Whaley, K. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108360108 · Cited by 229
Antibody response to a T-dependent antigen requires B cell expression of complement receptors.
Croix, D. A., Ahearn, J. M., Rosengard, A. M., Han, S., Kelsoe, G., Ma, M., & Carroll, M. C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1857 · Cited by 229
Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells
Peipp, M., Lammerts van Bueren, J. J., Schneider-Merck, T., Bleeker, W. W. K., Dechant, M., Beyer, T., Repp, R., van Berkel, P. H. C., Vink, T., van de Winkel, J. G. J., et al. (2008) · Blood · doi:10.1182/blood-2008-03-144600 · Cited by 222
Rodrigues, M. L., Travassos, L. R., Miranda, K. R., Franzen, A. J., Rozental, S., de Souza, W., Alviano, C. S., & Barreto-Bergter, E. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.7049-7060.2000 · Cited by 218
General mechanism for modulating immunoglobulin effector function
Sondermann, P., Pincetic, A., Maamary, J., Lammens, K., & Ravetch, J. V. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307864110 · Cited by 218
The human IgM pentamer is a mushroom-shaped molecule with a flexural bias
Czajkowsky, D. M., & Shao, Z. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903805106 · Cited by 206
Immune correlates of vaccine protection against HIV-1 acquisition
Corey, L., Gilbert, P. B., Tomaras, G. D., Haynes, B. F., Pantaleo, G., & Fauci, A. S. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac7732 · Cited by 205
Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response
Abès, R., Gélizé, E., Fridman, W. H., & Teillaud, J.-L. (2010) · Blood · doi:10.1182/blood-2009-10-248609 · Cited by 198
Borrow, R., Carlone, G. M., Rosenstein, N., Blake, M., Feavers, I., Martin, D., Zollinger, W., Robbins, J., Aaberge, I., Granoff, D. M., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.03.091 · Cited by 197
Neutrophil-Mediated Phagocytosis of Staphylococcus aureus
van Kessel, K. P. M., Bestebroer, J., & van Strijp, J. A. G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00467 · Cited by 196
He, W., Tan, G. S., Mullarkey, C. E., Lee, A. J., Lam, M. M. W., Krammer, F., Henry, C., Wilson, P. C., Ashkar, A. A., Palese, P., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609316113 · Cited by 182
Taborda, C. P., & Casadevall, A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00328-x · Cited by 175
Infections associated with the use of eculizumab: recommendations for prevention and prophylaxis
Benamu, E., & Montoya, J. G. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000279 · Cited by 167
More Is Not Necessarily Better: Prozone-Like Effects in Passive Immunization with IgG
Taborda, C. P., Rivera, J., Zaragoza, O., & Casadevall, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3621 · Cited by 166
A single glycan on IgE is indispensable for initiation of anaphylaxis
Shade, K.-T., Platzer, B., Washburn, N., Mani, V., Bartsch, Y. C., Conroy, M. E., Pagan, J. D., Bosques, C. J., Mempel, T. R., Fiebiger, E., et al. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20142182 · Cited by 162
Intracellular Antibody Neutralizes Listeria Growth
Edelson, B. T., & Unanue, E. R. (2001) · Immunity · doi:10.1016/s1074-7613(01)00139-x · Cited by 159
Wu, Y., Cho, M., Shore, D. A., Song, M., Choi, J.-A., Jiang, T., Deng, Y., Bourgeois, M. A., Almli, L. M., Yang, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms8708 · Cited by 158
Vincents, B., von Pawel‐Rammingen, U., Björck, L., & Abrahamson, M. (2004) · Biochemistry · doi:10.1021/bi048284d · Cited by 154
FcγRIIa Genotype Predicts Progression of HIV Infection
Forthal, D. N., Landucci, G., Bream, J. H., Jacobson, L. P., Phan, T. B., & Montoya, B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7916 · Cited by 153
IgD can largely substitute for loss of IgM function in B cells
Lutz, C., Ledermann, B., Kosco‐Vilbois, M. H., Ochsenbein, A. F., Zinkernagel, R. M., Köhler, G., & Brombacher, F. (1998) · Nature · doi:10.1038/31716 · Cited by 145
[On the development of immunity to diphtheria and tetanus in animals].
Behring, & Kitasato (1965) · PubMed · Cited by 142
The role and function of Fcγ receptors on myeloid cells
Bournazos, S., Wang, T. T., & Ravetch, J. V. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0045-2016 · Cited by 138
Modulation of the Effector Functions of a Human IgG1 through Engineering of Its Hinge Region
Dall’Acqua, W. F., Cook, K. E., Damschroder, M. M., Woods, R. M., & Wu, H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.1129 · Cited by 138
Yauch, L. E., Lam, J. S., & Levitz, S. M. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020120 · Cited by 135
Vogt, M. R., Dowd, K. A., Engle, M. J., Tesh, R. B., Johnson, S., Pierson, T. C., & Diamond, M. (2011) · Journal of Virology · doi:10.1128/jvi.05859-11 · Cited by 134
Cheung, N. V., Sowers, R. S., Vickers, A. J., Cheung, I. Y., Kushner, B. H., & Gorlick, R. G. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6011 · Cited by 122
Ryan, M. H., Petrone, D., Nemeth, J. F., Barnathan, E., Björck, L., & Jordan, R. E. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.10.043 · Cited by 122
Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3)
Plomp, R., Dekkers, G., Rombouts, Y., Visser, R., Koeleman, C. A. M., Lageveen‐Kammeijer, G. S. M., Jansen, B. C., Rispens, T., Hensbergen, P. J., Vidarsson, G., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.047381 · Cited by 121
Mullarkey, C. E., Bailey, M. J., Golubeva, D., Tan, G. S., Nachbagauer, R., He, W., Novakowski, K. E., Bowdish, D. M. E., Miller, M. S., & Palese, P. (2016) · mBio · doi:10.1128/mbio.01624-16 · Cited by 117
IgG in cervicovaginal mucus traps HSV and prevents vaginal Herpes infections
Wang, Y.-Y., Kannan, A., Nunn, K. L., Murphy, M. A., Subramani, D. B., Moench, T. R., Cone, R. A., & Lai, S. K. (2014) · Mucosal Immunology · doi:10.1038/mi.2013.120 · Cited by 112
A requirement for FcγR in antibody-mediated bacterial toxin neutralization
Abboud, N., Chow, S.-K., Saylor, C., Markmann, A. J., Ravetch, J. V., Scharff, M. D., & Casadevall, A. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100995 · Cited by 109
Brezski, R. J., Vafa, O., Petrone, D., Tam, S. H., Powers, G. D., Ryan, M. H., Luongo, J. L., Greenplate, A. R., Knight, D. M., & Jordan, R. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904174106 · Cited by 105
Postentry Neutralization of Adenovirus Type 5 by an Antihexon Antibody
Varghese, R. T., Mikyas, Y., Stewart, P. L., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12320-12332.2004 · Cited by 105
Antibodies and Their Receptors: Different Potential Roles in Mucosal Defense
Horton, R. E., & Vidarsson, G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00200 · Cited by 101
Sinha, S., Mishra, S. K., Sharma, S., Patibandla, P. K., Mallick, P. K., Sharma, S. K., Mohanty, S., Pati, S. S., Mishra, S. K., Ramteke, B. K., et al. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-13 · Cited by 100
Antibodies protect against intracellular bacteria by Fc receptor-mediated lysosomal targeting
Joller, N., Weber, S. S., Müller, A. J., Spörri, R., Selchow, P., Sander, P., Hilbi, H., & Oxenius, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013827107 · Cited by 99
Interleukin 10- and Fcγ Receptor-Deficient Mice ResolveLeishmania mexicanaLesions
Buxbaum, L. U., & Scott, P. (2005) · Infection and Immunity · doi:10.1128/iai.73.4.2101-2108.2005 · Cited by 98
Garcı́a, G., Sierra, B., Pérez, A. B., Aguirre, E., Rosado, I., González, N., Izquierdo, A., Pupo, M., Díaz, D. R. D., Sánchez, L., et al. (2010) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2010.09-0353 · Cited by 97
Ockenhouse, C. F., Regules, J. A., Tosh, D., Cowden, J., Kathcart, A. K., Cummings, J. F., Paolino, K. M., Moon, J. E., Komisar, J. L., Kamau, E. T., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131571 · Cited by 96
Isotype Can Affect the Fine Specificity of an Antibody for a Polysaccharide Antigen
McLean, G. R., Torres, M., Elguezábal, N., Nakouzi, A. S., & Casadevall, A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1379 · Cited by 94
Cockburn, J. J. B., Sanchez, M. E. N., Goncalvez, A. P., Zaitseva, E., Stura, E. A., Kikuti, C. M., Duquerroy, S., Dussart, P., Chernomordik, L., Lai, C., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.439 · Cited by 92
History and Practice: Antibodies in Infectious Diseases
Hey, A. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.aid-0026-2014 · Cited by 91
Jönsson, F., & Daëron, M. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00016 · Cited by 88
Yuan, R., Clynes, R., Oh, J. S., Ravetch, J. V., & Scharff, M. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.641 · Cited by 88
Cross-Talk between TLR4 and FcγReceptorIII (CD16) Pathways
Rittirsch, D., Flierl, M. A., Day, D. E., Nadeau, B. A., Zetoune, F. S., Sarma, J. V., Werner, C. M. L., Wanner, G. A., Simmen, H., Huber-Lang, M. S., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000464 · Cited by 87
Stavenhagen, K., Plomp, R., & Wuhrer, M. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b02366 · Cited by 85
Bolton, D. L., Pegu, A., Wang, K., McGinnis, K., Nason, M., Foulds, K. E., Letukas, V., Schmidt, S. D., Chen, X., Todd, J. P., et al. (2015) · Journal of Virology · doi:10.1128/jvi.02454-15 · Cited by 82
Long Term Maintenance of IgE-Mediated Memory in Mast Cells in the Absence of Detectable Serum IgE
Kubo, S., Nakayama, T., Matsuoka, K., Yonekawa, H., & Karasuyama, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.2.775 · Cited by 81
Serology in the 21st century: the molecular-level analysis of the serum antibody repertoire
Wine, Y., Horton, A. P., Ippolito, G. C., & Georgiou, G. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.06.009 · Cited by 76
Cooperativity Enables Non-neutralizing Antibodies to Neutralize Ebolavirus
Howell, K. A., Brannan, J. M., Bryan, C., McNeal, A. S., Davidson, E., Turner, H. L., Vu, H., Shulenin, S., He, S., Kuehne, A. I., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.049 · Cited by 75
Benhnia, M. R., McCausland, M. M., Laudenslager, J., Granger, S. W., Rickert, S., Koriazova, L. K., Tahara, T., Kubo, R. T., Kato, S., & Crotty, S. (2009) · Journal of Virology · doi:10.1128/jvi.01593-09 · Cited by 71
van Egmond, M., Vidarsson, G., & Bakema, J. E. (2015) · Immunological Reviews · doi:10.1111/imr.12333 · Cited by 69
Aiyegbo, M. S., Sapparapu, G., Spiller, B. W., Eli, I. M., Williams, D., Kim, R., Lee, D. E., Liu, T., Li, S., Woods, V. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061101 · Cited by 69
Choi, J. H., Wang, K.-W., Zhang, D., Zhan, X., Wang, T., Bu, C.-H., Behrendt, C. L., Zeng, M., Wang, Y., Misawa, T., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621258114 · Cited by 68
Human IgG Fc domain engineering enhances antitoxin neutralizing antibody activity
Bournazos, S., Chow, S.-K., Abboud, N., Casadevall, A., & Ravetch, J. V. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72676 · Cited by 66
Sun, Z., Almogren, A., Furtado, P. B., et al. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.07.072 · Cited by 65
Fc Receptors as Adaptive Immunoreceptors
Daëron, M. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-07911-0_7 · Cited by 64
Glycosylation of Immunoglobulin A Influences Its Receptor Binding
Basset, Devauchelle, Durand, Jamin, Pennec, Youinou, & Dueymes (1999) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1999.00628.x · Cited by 61
Mabry, R. L., Rani, M., Geiger, R., Hubbard, G. B., Carrion, R., Brasky, K. M., Patterson, J. L., Georgiou, G., & Iverson, B. L. (2005) · Infection and Immunity · doi:10.1128/iai.73.12.8362-8368.2005 · Cited by 61
McCloskey, M., de Lafaille, M. A. C., Carroll, M. C., & Erlebacher, A. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100354 · Cited by 60
How antibodies alter the cell entry pathway of dengue virus particles in macrophages
Ayala‐Nunez, V., Hoornweg, T. E., van de Pol, D. P. I., Sjollema, K. A., Flipse, J., van der Schaar, H. M., & Smit, J. M. (2016) · Scientific Reports · doi:10.1038/srep28768 · Cited by 59
Complement-Dependent Transport of Antigen into B Cell Follicles
González, S., Lukacs‐Kornek, V., Kuligowski, M., Pitcher, L. A., Degn, S. E., Turley, S. J., & Carroll, M. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000522 · Cited by 58
Herrada, A. A., Contreras, F., Tobar, J. A., Pacheco, R., & Kalergis, A. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700999104 · Cited by 56
Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells
Lee, W. S., Richard, J., Lichtfuss, M., Smith, A. B., Park, J., Courter, J. R., Melillo, B. N., Sodroski, J., Kaufmann, D., Finzi, A., et al. (2015) · Journal of Virology · doi:10.1128/jvi.02717-15 · Cited by 56
Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16
Gunn, B. M., Schneider, J. R., Shansab, M., Bastian, A. R., Fahrbach, K. M., Smith, A. D., Mahan, A. E., Karim, M. M., Licht, A. F., Zvonar, I., et al. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.8 · Cited by 56
Self-citationSolé‐Violán, J., García-Laorden, M. I., Marcos-Ramos, J. A., de Castro, F. R., Rajas, O., Borderías, L., Briones, M. L., Herrera‐Ramos, E., Blanquer, J., Aspa, J., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31820eda74 · Cited by 55
Association of Fcγ receptor IIIa genotype with the rate of HIV infection after gp120 vaccination
Forthal, D. N., Gabriel, E. E., Wang, A. Y., Landucci, G., & Phan, T. B. (2012) · Blood · doi:10.1182/blood-2012-05-431361 · Cited by 54
Kaur, R., Surendran, N., Ochs, M. M., & Pichichero, M. E. (2014) · Infection and Immunity · doi:10.1128/iai.02124-14 · Cited by 51
How Immunoglobulin G Antibodies Kill Target Cells
Biburger, M., Lux, A., & Nimmerjahn, F. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800147-9.00003-0 · Cited by 51
The influence of the hinge region length in binding of human IgG to human Fcγ receptors
Redpath, S., Michaelsen, T. E., Sandlie, I., & Clark, M. (1998) · Human Immunology · doi:10.1016/s0198-8859(98)00075-5 · Cited by 48
Senior, B. W., & Woof, J. M. (2005) · Infection and Immunity · doi:10.1128/iai.73.3.1515-1522.2005 · Cited by 43
Ishii, Y., Tanaka, K., Kondo, K., Takeuchi, T., Mori, S., & Kanda, T. (2010) · Virology · doi:10.1016/j.virol.2010.07.019 · Cited by 42
High Affinity Allele for the Gene of FCGR3A Is Risk Factor for HIV Infection and Progression
Poonia, B., Kijak, G. H., & Pauza, C. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015562 · Cited by 41
Boross, P., van Montfoort, N., Stapels, D. A. C., van der Poel, C. E., Bertens, C. J. F., Meeldijk, J., Jansen, J. H. M., Verbeek, J. S., OSSENDORP, F. A., Wubbolts, R., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302012 · Cited by 39
Zaragoza, Ó., & Casadevall, A. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00753.x · Cited by 36
Antibodies to PhnD Inhibit Staphylococcal Biofilms
Lam, H., Kesselly, A., Stegalkina, S. S., Kleanthous, H., & Yethon, J. A. (2014) · Infection and Immunity · doi:10.1128/iai.02168-14 · Cited by 35
Irani, V., Ramsland, P. A., Guy, A. J., Siba, P. M., Müeller, I., Richards, J. S., & Beeson, J. G. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ525 · Cited by 34
Wang, X., Kikuchi, T., & Rikihisa, Y. (2006) · Infection and Immunity · doi:10.1128/iai.74.3.1873-1882.2006 · Cited by 29
Can HIV-1-Specific ADCC Assist the Clearance of Reactivated Latently Infected Cells?
Lee, W. S., Parsons, M. S., Kent, S. J., & Lichtfuss, M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00265 · Cited by 27
Pignotti, M. S., Leo, M. C., Pugi, A., MASI, S. D., Biermann, K. P., Galli, L., Rosati, G. V., Buonocore, G., Mugelli, A., Dani, C., et al. (2016) · Pediatric Pulmonology · doi:10.1002/ppul.23561 · Cited by 22
Harvill, E. T., Osorio, M., Loving, C. L., Lee, G. M., Kelly, V. K., & Merkel, T. J. (2008) · Infection and Immunity · doi:10.1128/iai.00647-07 · Cited by 10
Conflicting roles of FcγRIIa H131R polymorphism in pneumonia*
Yende, S. P., & Wunderink, R. G. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318215bcd8 · Cited by 1
Cited by
Adaptive immunity to SARS-CoV-2 and COVID-19
Sette, A., & Crotty, S. (2021) · Cell · doi:10.1016/j.cell.2021.01.007 · Cited by 1,860
Diverse functional autoantibodies in patients with COVID-19
Wang, E. Y., Mao, T., Klein, J., Dai, Y., Huck, J. D., Jaycox, J. R., Liu, F., Zhou, T., Israelow, B., Wong, P., et al. (2021) · Nature · doi:10.1038/s41586-021-03631-y · Cited by 992
A perspective on potential antibody-dependent enhancement of SARS-CoV-2
Arvin, A. M., Fink, K., Schmid, M. A., Cathcart, A., Spreafico, R., Havenar-Daughton, C., Lanzavecchia, A., Corti, D., & Virgin, H. W. (2020) · Nature · doi:10.1038/s41586-020-2538-8 · Cited by 485
Winkler, E. S., Gilchuk, P., Yu, J., Bailey, A. L., Chen, R. E., Chong, Z., Zost, S. J., Jang, H., Huang, Y., Allen, J. D., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.026 · Cited by 366
Novel approaches for vaccine development
Gebre, M. S., Brito, L. A., Tostanoski, L. H., Edwards, D. K., Carfi, A., & Barouch, D. H. (2021) · Cell · doi:10.1016/j.cell.2021.02.030 · Cited by 347
Metadata
- Authors
- Lu, L. L., Suscovich, T. J., Fortune, S. M., & Alter, G.
- Venue
- Nature Reviews Immunology
- Published
- 2017-10-24
- Volume
- 18
- Issue
- 1
- Pages
- 46-61
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2766842037
- Cited by
- 825
- References
- 184
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.